Clinical Trials Logo
  1. Home
  2. Pre-diabetes
  3. NCT03961256

Assess the Efficacy and Safety of Exenatide SR for the Prevention of Diabetes After Kidney Transplantation

Pre Diabetes Clinical Trial

Official title:
A Phase 2, Prospective, Randomized, Multicenter, Open-Label, Controlled Trial to Assess the Efficacy and Safety of Exenatide SR for the Prevention of Diabetes After Kidney Transplantation.

Clinical Trial Summary

Researchers are trying to determine if an anti-diabetes medication, called Exenatide SR, is well tolerated in kidney transplant patients with elevated blood glucose levels, and if it's effective in preventing diabetes.

Clinical Trial Description

New diabetes can develop after transplant and may affect a transplanted kidney's health and a recipient's overall health. Currently, patients who are pre-diabetic are encouraged to exercise and lose weight. Researchers are planning to test whether an addition of this medication will lead to better results and more effectively prevent diabetes in patients who already have high blood sugars. Exenatide SR is medication given by weekly injection. It increases insulin release in response to a meal and slows digestion. This medicine is already in use and approved by the US Food and Drug Administration (FDA) in patients with diabetes. However, it has not been approved for this indication; the FDA has allowed the use of this drug in this research study. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT03961256
Study type Interventional
Source Mayo Clinic
Contact
Status Completed
Phase Phase 2
Start date May 9, 2019
Completion date October 18, 2021
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT05052918 - The Effect of Exercise and Metformin on Carotid Intima-media Thickness in Patients With Prediabetes N/A
Completed NCT03714646 - Beta Glucan and Acetate Production N/A
Completed NCT03377244 - Healthy Body Healthy Souls in the Marshallese Population N/A
Completed NCT04427982 - Dance and Diabetes/Prediabetes Self-Management N/A
Recruiting NCT05008276 - Puberty, Diabetes, and the Kidneys, When Eustress Becomes Distress (PANTHER Study)
Completed NCT03480022 - Liraglutide 3mg (Saxenda) on Weight, Body Composition, Hormonal and Metabolic Parameters in Obese Women With PCOS Phase 3
Active, not recruiting NCT05290233 - Time Restricted Eating Plus Exercise for Weight Management N/A
Withdrawn NCT05726409 - Mobile Application to Create Healthy Food Preparation Habits for Patients With Diabetes and Prediabetes N/A
Completed NCT02834078 - Effect of BGG on Glucose Metabolism and Other Markers of Metabolic Syndrome N/A
Completed NCT04902326 - Behavioral Economics and Self-Determination Theory to Change Diabetes Risk (BEST Change) N/A
Recruiting NCT04168372 - Fructose: Substrate, Stimulus, or Both? N/A
Completed NCT03272074 - Egg Consumption and Glycemic Control in Individuals With Pre- and Type II-diabetes N/A
Not yet recruiting NCT05939349 - A Prescription for Health Equity: A Healthcare Provider-based Produce Prescription Program for People With Prediabetes and Type 2 Diabetes N/A
Completed NCT04978376 - TRE With Physical Activity for Weight Management N/A
Recruiting NCT03997656 - A Digital Therapy for Diabetes Prevention Among Overweight Adults in Terengganu, Malaysia N/A
Recruiting NCT05166785 - BRInging the Diabetes Prevention Program to GEriatric Populations N/A
Completed NCT01729078 - Dietary Interventions in Prediabetes N/A
Completed NCT04507685 - Asian Indian Prediabetes Study N/A
Completed NCT03292315 - Once Weekly GLP-1 in Persons With Spinal Cord Injury Phase 4
Active, not recruiting NCT05353790 - Dietary Exchanges With Avocado and Mango in Pre-diabetes N/A